FDA Inspection 1042022 - Novel Laboratories, Inc. d.b.a Lupin Somerset - February 23, 2018
FDA Inspection 1042022 for Novel Laboratories, Inc. d.b.a Lupin Somerset on February 23, 2018. Classification: Voluntary Action Indicated (VAI).
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA Inspection 1042022 for Novel Laboratories, Inc. d.b.a Lupin Somerset on February 23, 2018. Classification: Voluntary Action Indicated (VAI).
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
February 23, 2018
Product Type
Drugs
ID: f74654d7-0457-44a8-9e57-74a0152e90f7
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox